A Study of GC203 TIL in Advanced Gynecologic Tumors (10hospital)

Clinical trial NCT05468307 · COMPLETED

Trial details

NCT number: NCT05468307
Sponsor: Shanghai Juncell Therapeutics
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Advanced Gynecologic Tumors TIL Engineered With Membrane-Binding Cytokine Treatment Side Effects Effects of Immunotherapy

Start date: 2022-03-10
Primary completion: 2024-12-30
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.